CareLit · DOI-Nachweis · Zeitschrift für Gastroenterologie
Delayed early HCV RNA response during IFN-free therapy with sofosbuvir in interferon-ineligible patients with advanced cirrhosis
DOI 10.1055/s-0034-1397220
Bibliografische Angaben
Nachweis in CareLit
Autor:innenK Deterding, C Höner zu Siederdissen, K Port, J Kirschner, L Sollik, C Mix, MP Manns, M Cornberg, H Wedemeyer
ZeitschriftZeitschrift für Gastroenterologie
Ausgabe01/2015
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Sofosbuvir has been approved for the treatment of patients with chronic hepatitis C in Europe in January 2014. Phase 3 trials suggested lower response rates to sofosbuvir treatment in patients with liver cirrhosis. However, there is limited information on the efficacy and safety of interferon-free sofosbuvir + ribavirin therapy in interferon-ineligible patients with advanced cirrhosis. Sofosbuvir and weight-based ri…
Zitieren
Zitierempfehlung
K Deterding, C Höner zu Siederdissen, K Port, J Kirschner, L Sollik, C Mix, MP Manns, M Cornberg, H Wedemeyer (2015) Delayed early HCV RNA response during IFN-free therapy with sofosbuvir in interferon-ineligible patients with advanced cirrhosis. Zeitschrift für Gastroenterologie (01). https://doi.org/10.1055/s-0034-1397220
Mit CareLit weiterarbeiten